From Europe. For the global patent community.
Trending Topics:
JUVE Patent European Patent Office

European Patent Office

Cases
EPO, CureVac, Covid19, Biontech, Pfizer
mRNA technology

Graf von Stosch scores wins for CureVac in EPO oppositions

In the extensive dispute over mRNA patents, CureVac has achieved a victory at the European Patent Office. The Opposition Division upheld two important ...

21 May 2025 by Konstanze Richter
Cases
Amgen, Repatha, Sanofi, Regeneron, Praluent, cholesterol-lowering drugs
Pharmaceuticals

EPO and UPC disagree on validity of Amgen's patent for cholesterol drug

The EPO Opposition Division has rejected a challenge by Sanofi and Regeneron against a key patent covering Amgen’s cholesterol-lowering drug Repatha. ...

15 April 2025 by Mathieu Klos
Cases
Edwards Lifesciences, Meril Life Science, transcatheter heart valves, EPO Boards of Appeal
Medical devices

Epic battle over heart valves continues as EPO revokes two Edwards patents

The EPO Boards of Appeal have revoked two divisional patents belonging to Edwards Lifesciences' heart valve portfolio. This latest development comes a ...

4 April 2025 by Mathieu Klos
People & Business
patents, applications, Unitary Patents, European patents, patents with unitary effect, EPO, European Patent Office, Patent Index
European Patent Office

EPO statistics show surge in Unitary Patents

Demand for European patents with unitary effect is rising across Europe, even as total patent applications at the European Patent Office showed a slig ...

26 March 2025 by Mathieu Klos
Cases
CRISPR/Cas, gene-cutting, genetic scissors, Nobel prize
CRISPR/Cas

Swerving the matter of granting genetic scissor patents at the EPO

This autumn, the EPO Boards of Appeal were supposed to issue landmark decisions in the battle for the basic patents on CRISPR/Cas9 technology. But the ...

28 November 2024 by Mathieu Klos
Cases
Novo Nordisk, semaglutide, opposition, weight-loss, diabetes
Blockbuster drug

Generic drug companies attack Novo Nordisk's diabetes and weight-loss drug

The Boards of Appeal of the European Patent Office have revoked two patents belonging to Novo Nordisk that are important for the administration of the ...

11 October 2024 by Mathieu Klos
People & Business
Dabus, AI, Federal Court of Justice, patent application
Interview

Malte Köllner: "You can file a patent application on an AI-assisted invention"

Artificial intelligence cannot be an inventor. The Federal Court of Justice recently decided this for Germany. The court nevertheless allowed the appl ...

25 July 2024 by Mathieu Klos
Legal Commentary
CMS, case management system, EPO, UPC
Opinion

"UPC pulls ripcord on CMS in time, but proximity to the EPO is questionable"

Last Friday the UPC declared it was to cooperate with the EPO on IT matters. Most importantly, it announced the development of a new case management s ...

24 July 2024 by Mathieu Klos
Sponsored Content NPE activity in Europe

European Patent Litigation and Non-Practicing Entities: A Large and Looming Threat

PAEs from the U.S are spreading to Europe, with eight out of the top ten most active NPEs in Europe being US-based companies. One in every seven infri ...

13 June 2024 by Unified Patents, LLC
Cases
Moderna, EP 949, BioNTech, Pfizer
mRNA technology

Düsseldorf Regional Court can proceed with trial after EPO upholds Moderna patent

Moderna has landed an important victory at the European Patent Office. The Opposition Division granted a key mRNA patent in the face of an objection f ...

24 May 2024 by Mathieu Klos
Legal Commentary
Boards of Appeal, BoA, EPO, quality, Annual Report
Opinion

"Figures show the EPO Boards of Appeal are highly productive, but it's only half the story"

The EPO Boards of Appeal have published their Annual Report 2024 and one aspect in particular stands out: in line with the current strategy, the court ...

21 May 2024 by Mathieu Klos
Cases
EPO Enlarged Board of Appeal

EBA to consider claim construction questions in heat-not-burn dispute

In Yunnan Tobacco vs. Philip Morris, the EPO Boards of Appeal will refer key questions on claim construction to the Enlarged Board of Appeal. If the E ...

22 April 2024 by Amy Sandys
People & Business
EPO Patent Index, unitary patent, UPC
European Patent Office

EPO Patent Index shows UPC effect as companies request unitary protection

Statistics released by the European Patent Office indicate that companies filing patents in Europe are increasingly interested in the Unitary Patent, ...

20 March 2024 by Amy Sandys
Cases
Akebia, Fibrogen, EPO
Pharmaceuticals

Akebia defends anaemia drug patents at EPO amid huge Fibrogen battle

Akebia Therapeutics has successfully defended two patents integral to a drug used to treat anaemia resulting from chronic kidney disease. The result i ...

1 March 2024 by Amy Sandys
Legal Commentary
EPO, Administrative Council, patent quality
European Patent Office

EPO staff petition Administrative Council to improve HR and patent quality

For weeks, some European Patent Office staff have been calling on management to reduce work pressure and improve quality in the granting of patents. N ...

28 February 2024 by Mathieu Klos
Popular